Ototoxicity of topical moxifloxacin in a chinchilla animal model

Laryngoscope

Volumn 117, Issue 12, 2007, Pages 2201-2205

  Daniel, Sam J ^a,b,c   Duval, Melanie ^a   Sahmkow, Sofia ^a   Akache, Fadi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c Montreal Childrens' Hospital ^*  (Canada)

Author keywords

Antibiotics; Chinchilla; Eardrops; Fluoroquinolones; Moxifloxacin; Ototoxicity

Indexed keywords

MOXIFLOXACIN; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINCHILLA; DISTORTION PRODUCT OTOACOUSTIC EMISSION; EARDRUM; FEMALE; HEARING; HEARING LOSS; NONHUMAN; OTOTOXICITY; PRESSURE EQUALIZING TUBE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUBE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; AZA COMPOUNDS; CHINCHILLA; COCHLEA; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; OTITIS; QUINOLINES;

EID: 40349114651     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318148b275     Document Type: Article

References (15)

1. Daniel SJ, Kozak FK, Fabian MC, et al. Guidelines for the treatment of tympanostomy tube otorrhea. J Otolaryngol 2005;34:S60-S63.
2. Dohar J, Giles W, Roland P, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulinic acid in acute oritis media with otorrhea through tympanostomy tubes. Pediatrics 2006;118:561-569.
3. Ikiz AO, Serbetcioglu B, Guneri EA, Sutay S, Ceryan K. Investigation of topical ciprofloxacin ototoxicity in guinea pigs. Acta Otolaryngol (Stockh) 1998;118:808-812.
4. Weber PC, Roland PS, Hannley M. The development of antibiotic resistant organisms with the use of ototopical medications. Otolaryngol Head Neck Surg 2004;130:S89-S94.
5. Jang CH, Park SY. Emergence of ciprofloxacin-resistant pseudomonas in pediatric otitis media. Int J Pediatr Otorhinolaryngol 2003;67:313-316.
6. Wake M, Anderson J, Takeno S, Mount RJ, Harrison RV. Otoacoustic emission amplification after inner ear cell damage. Acta Otolaryngol (Strockh) 1996;116:374-381.
7. Reyes S, Ding D, Sun W, Salvi R. Effect of inner and outer hair cell lesions on electrical evoked otoacoustic emissions. Hear Res 2001;158:139-150.
8. Van Bambeke F, Michot J-M, Val Eldere J, Tulkens PM. Quinolones in 2005: an update. Clin Microbiol Infect 2005;11:256-280.
9. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis 2006;43:1417-1422.
10. Goldblatt El. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. Pediatr Infect Dis J 2001;20:116-119.
11. Kakigi A, Hirakawa H, Harel N, Mount RJ, Harrison RV. Basal cochlear lesions result in increased amplitude of otoacoustic emissions. Audiol Neurol 1998;3:361-372.
12. Coates H, Hawke M, Manning SC, Vesterhauge S, Haynes DS, Detimer T. Strategies for managing granulation tissue. Ear Nose Throat J 2003;82(Suppl 2):21-24.
13. Roland PS, Anon JB, Moe RD, et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003;113:2116-2122.
14. Park SK, Choi D, Russell P, John EO, Jung TT. Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope 2004;114:768-771.
15. Roland PS, Rybak L, Hannley M, et al. Animal ototoxicity of topical antibiotics and the relevance to clinical treatment of human subjects. Otolaryngol Head Neck Surg 2004;130:S57-S78.